227 related articles for article (PubMed ID: 32139270)
1. Prognostic Significance of Androgen Receptor Expression in Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
Xu M; Yuan Y; Yan P; Jiang J; Ma P; Niu X; Ma S; Cai H; Yang K
Clin Breast Cancer; 2020 Aug; 20(4):e385-e396. PubMed ID: 32139270
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis.
Wang C; Pan B; Zhu H; Zhou Y; Mao F; Lin Y; Xu Q; Sun Q
Oncotarget; 2016 Jul; 7(29):46482-46491. PubMed ID: 27374089
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype.
McGhan LJ; McCullough AE; Protheroe CA; Dueck AC; Lee JJ; Nunez-Nateras R; Castle EP; Gray RJ; Wasif N; Goetz MP; Hawse JR; Henry TJ; Barrett MT; Cunliffe HE; Pockaj BA
Ann Surg Oncol; 2014 Feb; 21(2):361-7. PubMed ID: 24046116
[TBL] [Abstract][Full Text] [Related]
4. Association between androgen receptor status and prognosis in triple negative breast cancer.
Sunar V; T Dogan H; Sarici F; Ates O; Akin S; Baspinar B; Aksoy S; Altundag K
J BUON; 2018; 23(5):1325-1330. PubMed ID: 30570854
[TBL] [Abstract][Full Text] [Related]
5. Tumor characteristics and outcome by androgen receptor expression in triple-negative breast cancer patients treated with neo-adjuvant chemotherapy.
Jongen L; Floris G; Wildiers H; Claessens F; Richard F; Laenen A; Desmedt C; Ardui J; Punie K; Smeets A; Berteloot P; Vergote I; Neven P
Breast Cancer Res Treat; 2019 Aug; 176(3):699-708. PubMed ID: 31106385
[TBL] [Abstract][Full Text] [Related]
6. Quadruple-negative breast cancer: novel implications for a new disease.
Bhattarai S; Saini G; Gogineni K; Aneja R
Breast Cancer Res; 2020 Nov; 22(1):127. PubMed ID: 33213491
[TBL] [Abstract][Full Text] [Related]
7. Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
Ricciardi GR; Adamo B; Ieni A; Licata L; Cardia R; Ferraro G; Franchina T; Tuccari G; Adamo V
PLoS One; 2015; 10(6):e0128368. PubMed ID: 26039245
[TBL] [Abstract][Full Text] [Related]
8. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
9. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R
Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
11. The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients.
O'Rorke MA; Murray LJ; Brand JS; Bhoo-Pathy N
Cancer Treat Rev; 2016 Jun; 47():12-21. PubMed ID: 27214603
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis.
Zhang L; Fang C; Xu X; Li A; Cai Q; Long X
Biomed Res Int; 2015; 2015():357485. PubMed ID: 25695063
[TBL] [Abstract][Full Text] [Related]
13. Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer.
Goto Y; Thike AA; Ong CCH; Lim JX; Md Nasir ND; Li H; Koh VCY; Chen XY; Yeong JPS; Sasano H; Tan PH
J Clin Pathol; 2020 Mar; 73(3):147-153. PubMed ID: 31563883
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer.
Lyalkin SA; Verevkina NO; Alekseyenko OO; Syvak LA
Exp Oncol; 2020 Jun; 42(2):140-143. PubMed ID: 32602289
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.
Guiu S; Mollevi C; Charon-Barra C; Boissière F; Crapez E; Chartron E; Lamy PJ; Gutowski M; Bourgier C; Romieu G; Simony-Lafontaine J; Jacot W
Br J Cancer; 2018 Jul; 119(1):76-79. PubMed ID: 29880907
[TBL] [Abstract][Full Text] [Related]
16. Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review.
Yamaguchi J; Moriuchi H; Ueda T; Kawashita Y; Hazeyama T; Tateishi M; Aoki S; Uchihashi K; Nakamura M
BMC Cancer; 2021 Apr; 21(1):434. PubMed ID: 33879104
[TBL] [Abstract][Full Text] [Related]
17. The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis.
Lu YJ; Wang P; Wang X; Peng J; Zhu YW; Shen N
Oncotarget; 2016 Jun; 7(24):37361-37369. PubMed ID: 27008698
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor status is highly conserved during tumor progression of breast cancer.
Grogg A; Trippel M; Pfaltz K; Lädrach C; Droeser RA; Cihoric N; Salhia B; Zweifel M; Tapia C
BMC Cancer; 2015 Nov; 15():872. PubMed ID: 26552477
[TBL] [Abstract][Full Text] [Related]
19. Role of the androgen receptor in triple-negative breast cancer.
Rampurwala M; Wisinski KB; O'Regan R
Clin Adv Hematol Oncol; 2016 Mar; 14(3):186-93. PubMed ID: 27058032
[TBL] [Abstract][Full Text] [Related]
20. Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients.
Govindan S; Siraganahalli Eswaraiah M; Basavaraj C; Adinarayan M; Sankaran S; Bakre M
BMC Cancer; 2020 Aug; 20(1):745. PubMed ID: 32778063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]